- Home
- AAMI vs TNDM Comparison
AAMI vs TNDM Comparison
Compare AAMI & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAMI
- TNDM
- Stock Information
- Founded
- AAMI 1980
- TNDM 2006
- Country
- AAMI United States
- TNDM United States
- Employees
- AAMI N/A
- TNDM N/A
- Industry
- AAMI Investment Managers
- TNDM Medical/Dental Instruments
- Sector
- AAMI Finance
- TNDM Health Care
- Exchange
- AAMI Nasdaq
- TNDM Nasdaq
- Market Cap
- AAMI 960.9M
- TNDM 1.1B
- IPO Year
- AAMI N/A
- TNDM 2013
- Fundamental
- Price
- AAMI $30.35
- TNDM $22.85
- Analyst Decision
- AAMI Hold
- TNDM Buy
- Analyst Count
- AAMI 2
- TNDM 15
- Target Price
- AAMI $27.00
- TNDM $39.80
- AVG Volume (30 Days)
- AAMI 253.2K
- TNDM 1.7M
- Earning Date
- AAMI 05-01-2025
- TNDM 04-30-2025
- Dividend Yield
- AAMI 0.13%
- TNDM N/A
- EPS Growth
- AAMI 46.05
- TNDM N/A
- EPS
- AAMI 2.40
- TNDM N/A
- Revenue
- AAMI $519,799,999.00
- TNDM $982,951,000.00
- Revenue This Year
- AAMI $3.05
- TNDM $8.49
- Revenue Next Year
- AAMI $5.90
- TNDM $10.78
- P/E Ratio
- AAMI $12.70
- TNDM N/A
- Revenue Growth
- AAMI 18.00
- TNDM 27.65
- 52 Week Low
- AAMI $21.45
- TNDM $15.75
- 52 Week High
- AAMI $31.52
- TNDM $53.69
- Technical
- Relative Strength Index (RSI)
- AAMI N/A
- TNDM 66.36
- Support Level
- AAMI N/A
- TNDM $16.34
- Resistance Level
- AAMI N/A
- TNDM $24.00
- Average True Range (ATR)
- AAMI 0.00
- TNDM 1.05
- MACD
- AAMI 0.00
- TNDM 0.59
- Stochastic Oscillator
- AAMI 0.00
- TNDM 84.99
About AAMI Acadian Asset Management Inc. Common Stock
Acadian Asset Management Inc is a diversified, multi-boutique asset management company. It offers institutional investors across the globe access to a wide array of systematic strategies designed to meet a range of risk and return objectives.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.